USA flag logo/image

An Official Website of the United States Government

Company Information:

Address: 3601 Spruce Street
Suite G63
Philadelphia, PA
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $605,401.00 2

Award List:

Novel Inhibitors of Latent Epstein Barr Virus Infection

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Troy Messick
Award Amount: $268,700.00
DESCRIPTION (provided by applicant): The product that will result from this SBIR program, proposed by Vironika and its consortium partner, The Wistar Institute, is a new (the first) small molecule drug candidate for Epstein-Barr virus (EBV) latent infectio n, and its associated pathologies. EBV is a… More

Development of a Small Molecule Inhibitor for EBV Latent Infection

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mark Mcdonnell – 215-589-6415
Award Amount: $336,701.00
DESCRIPTION (provided by applicant): The goal of this SBIR research program is to develop a novel small molecule inhibitor of latent Epstein-Barr Virus (EBV) infection. EBV is a ubiquitous gamma- herpesvirus that has been classified by the World Health Organization as a human carcinogen. Vironika,… More